Nobel Prize in chemistry awarded to two women who developed CRISPR, a revolutionary gene-editing tool
By Ben Guarino,
Washington Post
| 10. 07. 2020
A pair of scientists — Jennifer A. Doudna, a biochemist at the University of California at Berkeley, and Emmanuelle Charpentier, a French microbiologist — won the 2020 Nobel Prize in chemistry Wednesday for their work developing a revolutionary gene-editing tool that can change the DNA of plants and animals with extraordinary precision. The technique, called CRISPR -Cas9, is already being used as a cancer therapy and to cure inherited diseases.
“This year’s prize is about rewriting the code of life,” said Goran K. Hansson, secretary general of the Royal Swedish Academy of Sciences.
This was the first time two women jointly won a Nobel in chemistry. “I wish that this will provide a positive message, specifically, to young girls who would like to follow the path of science,” Charpentier told reporters Wednesday morning.
“I’m over the moon, I’m in shock, I couldn’t be happier,” Doudna said at a University of California at Berkeley news conference. She said she and Charpentier are “waving to each other across the Atlantic right now.”
Francis Collins, director of the National Institutes of Health, said...
Related Articles
By Erik Adams, Sundance | 09.08.2026
The scariest movie playing at the 2026 Sundance Film Festival isn’t about cursed audio recordings or a killer demon disguised as your true love; rather it’s a 110-minute essay film about how a handful of guys obsessed with numbers and...
By Katie Bo Lillis and Zachary Cohen, CNN | 09.18.2026
The intelligence report, circulated across the US military this spring in the midst of the war with Iran, immediately set off alarm bells: A Chinese ship in the Middle East was transporting components of a nuclear weapons program.
The US...
By Miryam Naddaf, Nature | 09.21.2026
A wave of epigenetic therapies is offering hope as ways to cure chronic hepatitis B — a lingering liver infection that is caused by the hepatitis B virus (HBV) and affects more than 250 million people around the world. Currently...
By Karen Weintraub, Endpoints News | 09.16.2026
To better understand certain neuropsychiatric disorders, researchers at Stanford University have bred rodents that lack a cortex and hippocampus and then replaced those missing brain cells with human ones.
The altered mice, a scientific first, provided insights that would not...